We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Alert/Advisory
Alerts provide important advice about health products that may include safety information.
Latest alerts
-
Boston Scientific have advised that subsets of ACCOLADE and VISIONIST pacemakers have an increased risk of permanently entering Safety Mode which has limited functionality.
-
Pharmacists can use a Serious Scarcity Substitution Instrument (SSSI) to dispense Protaphane Penfill human insulin in the place of a Protaphane InnoLet cartridge.
-
Gold Max Blue capsules pose a serious risk to your health and should not be taken.
Latest articles
-
Recall reforms update and new procedure
Recall reforms program update and preview of the PRAC Version 1.0. -
Elemental impurities in traditional Chinese medicines (TCMs)
TCMs sold in Australia are carefully regulated to ensure safety and quality. -
Promethazine hydrochloride (Phenergan) not to be used in children under 6
Health professionals and consumers are advised that the oral antihistamine promethazine hydrochloride, sold as Phenergan and other generic brands, should not be used in children under 6 years of age.
Latest publications
-
In consultation with the TGA, Edgewell has taken a precautionary approach and commenced a recall of all batches of these three products from the Australian market.
-
TGA Laboratories has released a report detailing testing of alkyl nitrite products